Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

http://www.wikidata.org/entity/Q34994270

about

Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms Mitochondria and reactive oxygen species: physiology and pathophysiology Permeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of amyloid beta1-42 on neural progenitor cell proliferation.Neuroprotective effects of phenylethanoid glycosides in an in vitro model of Alzheimer's disease.Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis.Mitochondria-targeting particles.Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats.Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration?Induction of methionine-sulfoxide reductases protects neurons from amyloid β-protein insults in vitro and in vivo.Synaptic mitochondrial pathology in Alzheimer's disease Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Mechanism of oxidative stress in neurodegeneration.Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.Ginsenoside Rg1 attenuates oligomeric Aβ(1-42)-induced mitochondrial dysfunction.Rationally Designed CeNP@MnMoS4 Core-Shell Nanoparticles for Modulating Multiple Facets of Alzheimer's Disease.Antioxidant therapies for Alzheimer's disease Methionine sulfoxide reductase A affects β-amyloid solubility and mitochondrial function in a mouse model of Alzheimer's disease.Nutritional contributions to dementia prevention: main issues on antioxidant micronutrients.Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.Bioenergetic medicine.Collaborative Management of Neurocognitive Disorders in Primary Care: Explorations of an Attempt at Culture Change.Nuclear and mitochondrial DNA oxidation in Alzheimer's disease.Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.β-Amyloid peptides and amyloid plaques in Alzheimer's disease.Oxidative Stress, Inflammation, and Neuroprogression in Chronic PTSD.Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment.Neuroprotective effects of anthocyanins on apoptosis induced by mitochondrial oxidative stress.Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.

P2860

Q26830740-6CB5A8AC-6E7A-42B6-BF08-5DD47B6D8B0F Q27338799-04BB1BEF-59D3-4B4C-A52D-0C66E7190E8A Q28259424-8E0A3A2A-5605-4028-BCFE-700B1D362F33 Q28397259-33447228-0584-468F-BDF9-FC8C67D9F8A0 Q30573641-802055B2-2EB8-4FF4-A296-09D82A1538F0 Q33723958-9DEF984E-C9B5-428F-B90D-1678BC3CA9BD Q34299928-10DC7675-3557-4D98-9386-E5B16793DE68 Q34407220-E0FDCC86-AFF9-4E34-8803-BDB0311FC346 Q34415974-0EADACB7-33F0-420B-BAED-5D92B919E7F2 Q34960940-7B256BBE-7984-4D38-83A8-21DF091D5E43 Q35176315-6985239E-BE7E-4F64-BFE2-819AA4365F6B Q35595418-51B0A4DA-C28D-4ECF-92D7-E89EC9E8ADBE Q35606240-F7E73231-8DD5-4644-876C-41062FBC0E70 Q35898625-196B515E-DB5D-4EE9-BC8C-38C70137ECA5 Q35958359-90C297AC-D11E-4BB1-A6B5-F60CC5C87FE8 Q35996874-A475FA55-4A08-4EB8-9122-D3A3F563B381 Q36026546-6B04B47B-6099-4431-BCC4-4C3548FA956E Q36054716-CBA9C349-8381-444E-8849-35DBC1190FF4 Q36094624-4EFB2480-15E2-404F-A408-9AFAE0B819DB Q36135040-AE5BE8F9-960D-4C95-B6FD-11B8B9DD343C Q36698716-F44216F8-75D0-4EC0-B5D0-A447FACB2428 Q37669838-A2063BB7-166B-4048-B128-B449136E7490 Q37675866-242F762E-8AC6-49D0-816B-7670C9B3CF8A Q37686246-106C2096-C62D-4FC1-AC08-3DDA155F1E14 Q37718734-DDEDD3BD-26C2-45A2-846B-21948F08C43C Q37965702-BDCB0FD5-DFE3-4735-B512-6AE44BCD18F4 Q38253060-3B5CCEBF-26C5-42C5-8AAE-AAB776EACB4E Q38265124-60A011D3-3992-46C8-B89E-BA19E82F83BF Q47675785-94B8766E-D998-4BBC-94E6-83B6A5CB976C Q48413804-ABC01E02-43C8-4F55-8F7B-979D1F6EF4C8 Q50508432-FD9434D1-008A-416B-B489-73D0CC78AA6F Q50849964-FB30864E-B882-4D9A-A3DF-0CDE0A988BA1

P2860

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

http://www.wikidata.org/entity/Q34994270

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@ast

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@en

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@nl

type

label

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@ast

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@en

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@nl

prefLabel

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@ast

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@en

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@nl

P1433

Q34994270-5EE84293-D2CC-44C7-8558-6BB366F2C18C

P1476

Q34994270-DAB4040A-D040-4315-A442-F83C10907FF4

P2093

Q34994270-13ABEC87-1190-42BA-AAB9-D1ABEC92D242

Q34994270-8AA29317-8E82-4970-909B-2F0B6D8BF188

Q34994270-F5CCA61C-7860-4771-A190-AB3DAF1510B3

P2860

Q34994270-015F0E82-18B9-4A12-93E4-257B4EED1958

Q34994270-027666A7-04F0-4B3B-A4DF-65074F6D827C

Q34994270-05ED851A-BE11-4FEB-B49E-313E61D418CD

Q34994270-07351B6A-6ACA-402C-8548-A6C7EE3B8DE4

Q34994270-08DB092F-DB3B-4847-A79E-40FF644E6FE2

Q34994270-0BEB4067-537F-4033-83BF-6396D6E39B9D

Q34994270-139868F6-F163-418B-B490-609154CC833A

Q34994270-14F53DA0-BE21-4082-A375-01094970564B

Q34994270-1697A2E3-9137-41BB-BCC6-42DC6C4F4E13

Q34994270-190FE360-9F20-458D-8123-FAEF662602D5

P304

Q34994270-6FC5B176-73E6-4356-9304-8125CE4E1AD6

P31

Q34994270-008751CE-78E7-4743-B8B7-97F846B77912

P356

Q34994270-0E01C339-223F-4212-8D98-7D64225698D7

P478

Q34994270-360779B1-BFA8-4AD4-B97E-E825A7DEF3E3

P577

Q34994270-1C8A776D-A1DA-4BFB-9D50-7DD0030C488C

P5875

Q34994270-F7C27621-873B-4883-87F8-3640CFAF5E13

P698

Q34994270-5B2FD40B-8DA2-4348-92D8-77CC1BF02D90

P921

Q34994270-E3AE90FD-31A5-4706-A756-7FFF5A2FCCF8

Q34994270-E5892510-0C70-4F9C-8816-816F78B4BBA0

P932

Q34994270-A6D5B276-330C-400B-8308-DDFD061C0E10

P356

JAD-2010-100507

P1433

Journal of Alzheimer's Disease

P1476

Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease.

@en

P2093

M Flint Beal

http://www.w3.org/2001/XMLSchema#string

Magali Dumont

http://www.w3.org/2001/XMLSchema#string

Michael T Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Antioxidative Protection by Melatonin: Multiplicity of Mechanisms from Radical Detoxification to Radical Avoidance

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia

The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress

Effects of grape seed-derived polyphenols on amyloid beta-protein self-assembly and cytotoxicity

Mitochondria as a target for neurotoxins and neuroprotective agents

Dimebon and tacrine inhibit neurotoxic action of beta-amyloid in culture and block L-type Ca(2+) channels

Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons

P304

S633-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-2010-100507

http://www.w3.org/2001/XMLSchema#string

P478

20 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43345888

http://www.w3.org/2001/XMLSchema#string

P698

20421689

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3098571

http://www.w3.org/2001/XMLSchema#string